Metabolic measures 12 months after a randomised controlled trial of treatment of clozapine associated obesity and diabetes with exenatide (CODEX)
Dan Siskind, Anthony Russell, C Gamble, Andrew C. Baker, Peter Cosgrove, Laura Burton, Steve Kisely
Topics & Concepts
ExenatideMedicineClinical endpointMetforminWeight lossType 2 diabetesInternal medicineWeight gainLiraglutideRandomized controlled trialPlaceboObesityDiabetes mellitusEndocrinologyInsulinBody weightAlternative medicinePathologyDiabetes Treatment and ManagementPharmacology and Obesity TreatmentSchizophrenia research and treatment